Mural Oncology • MURA
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Caroline Loew, PhD$60.6M
Market Cap • 26/04/20242017
(há 7 anos)
2023
(1 year ago)
NASDAQ
Listagem
Dublin
Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MURASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.